Thomas Strüngmann
Encyclopedia
Thomas Strüngmann founded generic drug
maker Hexal AG ($1.6 billion sales during 2004) in 1986. In February he and his brother sold Hexal and their 67.7% of U.S. Eon Labs to Novartis
for $7.5 billion.
Generic drug
A generic drug is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended use." It has also been defined as a term referring to any drug marketed under its...
maker Hexal AG ($1.6 billion sales during 2004) in 1986. In February he and his brother sold Hexal and their 67.7% of U.S. Eon Labs to Novartis
Novartis
Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number three in sales among the world-wide industry...
for $7.5 billion.